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INTRODUCTION
Empyema thoracis (ET) is a serious infection of the
pleural space. Despite the availability of broad spectrum
antibacterial, improved vaccination coverage and
availability along with better diagnostic tools; ET
remains associated with high morbidity worldwide.1
Pathologically, empyema develops in three stages;
exudative, fibrinopurulent stage and organized stage.2,3
The incidence of childhood ET has increased since last
two decades while childhood pneumonia leading to
empyema accounts for 0.6%.4,5 There is a rise in the
incidence of ET, partly because of multi-drug resistant
pathogenic microorganism.5 Delay in early diagnosis,
failure to institute appropriate antimicrobial therapy, multi-
drug resistant organisms, malnutrition, comorbidities,
poor health seeking behavior and high treatment cost
burden contribute to increased morbidity in children.1,4-7
Staphylococcus aureus outnumber Streptococcus
pneumonia and Haemophilus influenza (Hib) because of
effective vaccine in developed countries.5,8 Hib vaccine
was included into Pakistan expanded programme on
immunization (EPI) in 2008. This vaccine is highly
effective and has enormous impact of Hib infection
worldwide. At the time of writing this paper Pneumo-
coccus vaccine was approved in the current vaccination
schedule for all Pakistani children. Impact of vaccine
after introduction would take at least 5 years. Among
the top causes of ET in children, Pneumococcus and
Staphylococcus aureus outnumber Mycobacterium
tuberculosis and other gram negative bacteria.7 It is
essential to have microbiological diagnosis for the
optimal management in empyema patients even though
the low microbiological yield of pleural fluid,3 that has led
to increasing use of molecular methods for the detection
of microorganisms by using polymerase chain reaction
(PCR) technique.8
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ABSTRACT
Objective: To determine the etiology, clinical manifestation, management (medical and surgical) and complications of
children with empyema thoracis in a tertiary care hospital from Karachi, Pakistan.
Study Design: Descriptive, analytical study.
Place and Duration of Study: Department of Surgery, The Aga Khan University Hospital, Karachi, from January 1996 to
December 2010.
Methodology: Medical records of admitted children aged > a month to 15 years with discharge diagnosis of empyema
thoracis and data was collected on demographic features, clinical manifestation, management and complications. Children
managed medically were compared with those managed surgically by using interquartile range and median comparison.
Mann-Whitney U test was used to compare age in months, weight (kg) and length of stay in days and presenting
complaint, duration of illness; chi-square test was used to compare thrombocytosis in between groups and p-value was
calculated.
Results: Among the 112 patients, 59 (53%) were younger than 5 years of age. Males (n=83, 74%) were predominant.
Fifty (45%) children were admitted in winter. Thirty (27%) children found unvaccinated and one fourth (n=27; 24%) were
severely malnourished. Fever, cough, and dyspnea were the major presenting symptoms. Sixty-six (59%) were on some
antibiotics prior to admission. Staphylococcus aureus (n=13) and Streptococcus pneumoniae (n=5) were the commonest
organism isolated from blood and pleural fluid cultures. Majority of the children required some surgical intervention (n=86).
Surgically managed children were younger (p=0.01); had less weight (p=0.01) and prolonged fever (p=0.02); and stayed
longer in hospital (p < 0.001) as compared to medically managed children. Requiring readmission (n=8), subcutaneous
emphysema (n=5) and recollection of pus (n=5) were the major complications.
Conclusion: Staphylococcus aureus was the major organism associated with paediatric empyema thoracis. Early
identification and empiric antibiotic as per local data is essential to prevent short and long-term complications. Younger,
lower weight children with prolonged fever required surgical management.
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Optimal management of pediatric empyema is still
controversial and the best management option is still not
clear.9 The available treatment options include intra-
venous broad spectrum antibiotics either alone or in
combination with surgical procedure (thoracocentesis,
chest tube drainage, fibrinolytic therapy, decortications
with video assisted thoracoscopic surgery (VATS) and
open drainage.10
There is dearth of knowledge regarding empyema or
parapneumonic effusion (PPE) in Pakistan. There are
very few centres with VATS availabilities and expertise in
children. The aim of this study was to describe the
clinical characteristics, bacterial etiology, management
and complications in children with discharge diagnosis
of PPE and empyema at The Aga Khan University
Hospital, Karachi.
METHODOLOGY
Medical records of all children (aged 1 month - 15 years)
with discharge diagnosis of PPE and/or empyema at
The Aga Khan University Hospital, Karachi, during the
period from January 1996 to December 2010, were
retrospectively reviewed.
Cases were selected by searching coded discharge
records for the terminologies parapneumonic effusion
and empyema with International Classification of
disease (ICD-9) 510 and 511.9 respectively. Medical
records were also retrieved by using ICD-9 procedure
category for decortication and chest wall procedure
(tube thoracostomy) 34.28 and 34.51.
Patients who were chronically ill, immunocompromised,
underlying malignancy or on PPE/empyema treatment
or had surgical procedure at the time of admission were
excluded. Patients with non-infectious etiologies leading
to pleural effusion and having chest tube thoracostomy
or thoracotomy were also excluded. Data including
medical record number, age in months, gender,
vaccination status, antibiotic therapy prior to hospitali-
zation, weight for age, presenting complaints, laboratory
investigations (anemia,11 leukocytosis (WBC > 10,000),
thrombocytosis (platelet count > 400)); site of PPE
(right, left or both), management procedure (surgical
or medical management), isolated microorganism
(bacterial cultures from blood and/or pleural fluid),
duration of antibiotic and disease or procedure related
complications were recorded. All patients received
antibiotic therapy.
Statistical analysis was performed by using Statistical
Package for Social Sciences (SPSS) version 19.
Continuous variables including age (in months), weight
on admission (kg), duration of presenting illness (i.e.,
duration of fever and cough), duration of hospital stay,
duration of chest drain placement were mentioned in
mean and standard deviation; however, categorical
variables i.e., (gender, vaccination status, site of chest
involvement, laboratory parameters, presence of
loculation, complications, follow-up duration and
discharge disposition) were mentioned in frequency and
percentages. Normality assumption was checked of the
study parameters. Age, weight, presenting complaints
(fever and cough) and length of stay were computed for
interquartile range and median comparison. Mann-
Whitney U test was used to compare age in months,
weight (kg), and length of stay in days and presenting
complaint, duration of illness; chi-square test was used
for comparing thrombocytosis in between groups and
p-value was calculated. P-value < 0.05 were taken as
significant.
RESULTS
A total of 112 children were discharged with diagnosis of
empyema thoracis or parapneumonic effusion during
1996 to 2010. Mean age was 71 ± 54 months (median
53 mon); 59 (53%) were five years or younger. Males
were predominant (n=83; 74%); majority of them were
admitted during winter season (n=50; 45%). Fever
(n=106, 95%), cough (n=77, 69%) and shortness of
breath (n=52, 46%) were the major presenting
complaints. Thirty (27%) children did not receive any
vaccination, while 27 (24%) were severely malnourished.
Sixty-six (58%) were on some antibiotics when
presented. Right side of chest was involved in 54%
(n=61), left side in 41% (n=47) while 3% (n=4) patients
had bilateral chest involvement on chest X-ray. Multi-
loculated empyema was seen in 46 (41%) of patients.
Blood and pleural fluid culture yield is shown in Table I.
Staphylococcus aureus was the most common isolated
organism (n=13). Six children had tuberculosis and on
its treatment before admission; later on two pleural fluid
cultures were positive for Mycobacterium tuberculosis.
Eighty-six (77%) children were managed surgically
{(chest drain only (n=25; 29%); chest drain and
decortication (n=59; 69%); chest drain, decortication and
pneumonectomy (n=2; 2%)} while rests were managed
with antibiotics and supportive treatment only. Surgically
managed children were younger (p=0.01); had
prolonged history of fever (p=0.02); had more cough and
less weight (p=0.01) as compared to the children
managed medically. Table II shows the differences in
both groups. Children managed medically has shorter
length of stay (p = < 0.001) and less thrombocytosis
(p=0.06) compared to children managed surgically.
Forty-one (37%) patients were discharged with chest
drain, and total duration of chest drain was 12 ± 11 days.
Eight patients were readmitted within 72 hours of
discharge. Fifteen patients developed complications
{subcutaneous emphysema (n=5); recollection of pus
(n=5); rib osteomyelitis (n=2); bronchopulmonary
fistulae (n=2); and pneumatocele (n=1)}. Most of the
patients (80%) were followed-up in the clinic for 4 - 6
weeks.
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Three patients died; 2 admitted with severe pneumonia
and empyema and respiratory failure, found to be
necrotizing pneumonitis and one with severe sepsis, and
disseminated intravascular coagulation.
DISCUSSION
Parapneumonic effusion (PPE) and empyema thoracic
(ET) are the sequels of pneumonia and occurred
mostly with inappropriate management of pneumonia
(inappropriate antimicrobial choice, dosing and interval;
delayed treatment strategy); or/and with poor host
response against virulent organism (i.e., immuno-
suppressed patients).2 In most of the developing
countries including Pakistan problematic functional
infrastructure (primary health care services and basic
health units), unsatisfactory vaccination coverage, high
tuberculous prevalence along with high chronic
malnutrition might increase the chance for empyema.12
The incidence of ET ranges between 0.6 - 0.8% in
subcontinent region;13 however, there is lack of literature
regarding ET incidence and/or prevalence in Pakistani
children. Infants and children, because of certain
features, tend to develop ET more as compared to older
children.5,13,14 This holds true for our study population,
where younger children developed more disease as
compared to elder. The disease is more prevalent in
winter season.5 Males were predominant in our study as
also mentioned elsewhere.5,14 Certain factors i.e.,
severe malnutrition (stunting and undernutrition),
unvaccinated child, inappropriately managed pneumonia,
immunodeficiency, overcrowding and poverty are
associated with ET in children.3,9,13,15,16 Severely
malnourished children predisposed to recurrent patho-
genic microbial infections of respiratory and gastro-
intestinal tract of varying intensity compared to normal to
moderately malnourished children.12 One of the major
predisposing factors of ET in our study population could
be severe malnutrition, which has been observed in the
previous studies.13,15
EPI-Pakistan has introduced the Haemophilus influenza
vaccination in 2008 and pneumococcal vaccination is
now able to make its place in the current vaccination. At
the time of writing this manuscript, a majority of Pakistani
population has access to EPI available pneumococcal
(PCV 10) vaccine. Two-third of this study population
were unvaccinated and majority of them were found
unvaccinated for H. influenza. Both H. influenza and
pneumococcus culture yield was very low, therefore it is
difficult to estimate the disease burden on the basis of
culture positivity.
Culture yield for pleural fluid was very low (ranging 3 -
33%).17,18 The pleural fluid culture yield was 29%
(Table I). Poor yield could possibly be because of prior
antimicrobial therapy and/or less bacterial inoculum in
the collected sample. Staphylococcus aureus and
Streptococcus pneumoniae remains the major bacterial
etiological microorganisms reported worldwide.5,8,19
Staphylococcus aureus has been the most isolated
bacteria in this study cohort. Five patients' cultures were
positive for Streptococcus pneumoniae. Serotyping
could not be done, however, the data suggest that
serotype 1, 14 and 3 are the commonest serotypes.14
Mycobacterium tuberculosis is endemic in Pakistan.
Every year many children and adults are infected with
this slow growing but highly morbid microorganism
which causes empyema in adults as well as in children.7
Six patients had tuberculosis. Almost all patients were
symptomatic 2 weeks before developing empyema and
were on antituberculous therapy.
Most of the children were managed surgically in our
study cohort. Clinical features like lethargy, persistent
spiking of fever with increased respiratory distress,
along with progressive fluid accumulation on Radiology
despite broad spectrum antibiotic cover warrants
immediate evacuation of pleural content and also to re-
expand the lung.3 Children who are younger and having
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Table I: Isolated from bacterial blood and pleural fluid culture.
Microorganism Pleural fluid (n) Blood (n)
Staphylococcus aureus 11 2
Staphylococcus epidermidis 3 2
Streptococcus pneumoniae 3 2
Pseudomonas aeruginosa 3 1
Klebsiella pneumoniae 1 2
Haemophilus influenzae -- 3
Enterobacter species -- 2
Mycobacterium tuberculosis 2 --
Salmonella typhi 1 --
Acinetobacter species 1 --
Enterococcus species 1 --
(n) number of patients.
Table II: Comparison of medical and surgically managed children.
Only managed Surgically p-value**
medically intervention
(n = 26) (n = 86)
Age (mo.)* 96 (107.3) 45 (79) 0.01 
Weight (kg)* 24 (18) 14 (13.2) 0.01
Presenting complaint (days)*
Fever 6 (12.8) 15 (20.3) 0.02
Cough 14.5 (94) 15 (93) 0.80
Thrombocytosis (%)*** 9 (36.4%) 49 (56.9.3%) 0.06
Length of stay (days)* 5 (6.3) 9 (7) < 0.001
* Median (inter quartile range); (n) number of patients; ** Mann-Whitney U-test for age, weight
and length of stay, days with presenting complaints; *** Chi-square test for thrombocytosis.
Table III: Children with PPE complications (n=112).
Readmission 8 (7%)
Subcutaneous emphysema 5 (4%)
Recollection of pus 5 (4%)
Bronchopulmonary fistulae 2 (2%)
Rib osteomyelitis 2 (2%)
Pneumatocele 1 (1%)
 
symptoms for a longer duration were managed with
surgical intervention along with medical management in
this study cohort with significant statistical value
(Table II). Unfortunately, there is no definite point at
which one should proceed for surgical drainage;
however, one should consider the above-mentioned
measures as to proceed for surgery. It is reported that
only 10% of patients with PPE required needle or tube
drainage, but it is also important not to delay this as it
can become loculated or organized and then difficult to
drain.8 Children who required surgical intervention may
be because of wrong antibacterial drug and/or dosage,
their poor response to initial antibacterial therapy and/or
virulence of microorganism. Children managed
surgically found to be younger in our study cohort. VATS
is far better than conventional open drainage in
children.20 The possible reason might be that they were
sicker and needed immediate surgical intervention.
There were certain limitations of this study. It was one
center study therefore; results should be generalized
with caution. Because of retrospective nature of chart
review, authors were dependent on the physicians'
documentations. There were certain missing information;
however, all the possible measures were taken to collect
the information.
CONCLUSION
Paediatric empyema thoracis is associated with
increased morbidity. Early recognition is the key leading
to optimum management, which depends upon the
stage at presentation. Every case of pneumonia should
be managed with high index suspicion and should be
followed.
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